Biden Administration Announces Another Step Toward Government Takeover of American Healthcare
December 8, 2023 This week, the Biden administration announced plans to drastically expand the use of Bayh-Dole Act “march-in”...
December 8, 2023 This week, the Biden administration announced plans to drastically expand the use of Bayh-Dole Act “march-in”...
March 9, 2023 President Biden traveled to Philadelphia today to sell Americans on his budget proposal for the 2024...
June 29, 2020 As an advocate for consumers across the country, CASE urges House lawmakers to vote against H.R. 1425,...
March 4, 2020 CASE issued the following statement this morning regarding attempts by some in Congress to use corona virus...
December 5, 2019 Click Here to see full coalition letter. Text of Letter: We represent fiscal conservatives and free...
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that...
On Saturday, the world recognized World AIDS Day. Since it was first recognized as a cause of death in the...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers